Withdrawn before it began
Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila
NCT07111039 · H. Lee Moffitt Cancer Center and Research Institute · Updated 18 May 2026
- What is being tested
- Airway Pressure Release Ventilation; Conventional Mechanical Ventilation
- For
- Gynecologic Cancer; Genitourinary Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started March 2026, ends July 2028. Registered 8 Aug 2025.
- Results
- None posted yet.
In the researchers' words
This is a pilot study to determine if pulmonary function (lung compliance and ventilation/perfusion matching) is improved using APRV during general anesthesia, compared to the standard CMV. APRV will be tested during anesthesia in 12 patients undergoing robotic-assisted gynecological or genitourinary surgical procedures for definitive cancer treatment, who will also receive CMV.
Sites
- Moffitt Cancer CenterTampa, Florida, United States